Cancer drug firm Carrick to begin ‘multi-portfolio’ clinical trials within year
Dublin-based firm aiming to fight aggressive forms of cancer has raised $95m from investors
Carrick Therapeutics, the Dublin-headquartered drug company launched last week, said it hopes to have its compounds for cancer treatments undergoing clinical trial in a year.
Co-founder Elaine Sullivan told The Sunday Business Post that the company was currently working with scientists on programmes to target three areas – using “molecular pathways” – to fight some of the most aggressive forms of cancer.
“We want to create a multi-portfolio [drug] company and we identified three assets and...
Subscribe from just 1€
Choose the subscription that is right for you
For the first month
€19.99 Monthly ThereafterSubscribe today
For the first year
€199.99 annually thereafterSubscribe today
For the first 90 days
€55.00 quarterly ThereafterSubscribe today
These offers are not available for current subscribers. Offers and pricing are subject to change without notice.
Terms & Conditions Apply